It comes after Pharmaceutical Services Negotiating Committee (PSNC) committee members met last week to discuss what “other steps businesses might need to take in the absence of additional funding”, the negotiator revealed.
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?